Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis

Kidney International

Volumn 63, Issue 5, 2003, Pages 1801-1808

  Salusky, Isidro B ^a   Goodman, William G ^b   Kuizon, Beatriz D ^b   Lavigne, Jeffrey R ^b   Zahranik, Richard J ^b   Gales, Barbara ^b   Wang, He Jing ^b   Elashoff, Robert M ^b   Jüppner, Harald ^b  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Immunometric PTH assay; Parathyroid hormone; Peritoneal dialysis

Indexed keywords

PARATHYROID HORMONE; PARATHYROID HORMONE[7-84]; UNCLASSIFIED DRUG;

ADOLESCENT; AMINO TERMINAL SEQUENCE; ARTICLE; BONE BIOPSY; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; FEMALE; HORMONE DETERMINATION; HUMAN; ILIAC CREST; MALE; MOLECULAR RECOGNITION; OSSIFICATION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SCHOOL CHILD; SECONDARY HYPERPARATHYROIDISM;

EID: 0037407212     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00915.x     Document Type: Article

References (42)

1. GOODMAN WG, COBURN JW, SLATOPOLSKY E, SALUSKY IB: Renal osteodystrophy in adults and children, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed, edited by FAVUS MJ, Philadelphia, Lippincott, Williams and Wilkins, 1999, pp 347-363
2. SHERRARD DJ, BAYLINK DJ, WERGEDAL JE, MALONEY NA: Quantitative histological studies on the pathogenesis of uremic bone disease. J Clin Endocrinol Metab 39:119-135, 1974
3. SALUSKY IB, COBURN JW, BRILL J, et al: Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975-982, 1988
4. MALLUCHE HH, MONIER-FAUGERE MC: The role of bone biopsy in the management of patients with renal osteodystrophy. J Am Soc Nephrol 4:1631-1642, 1994
5. SHERRARD DJ, HERCZ G, PEI Y, et al: The spectrum of bone disease in end-stage renal failure - An evolving disorder. Kidney Int 43:436-442, 1993
6. COHEN-SOLAL ME, SEBERT JL, BOUDAILLIEZ B, et al: Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516-524, 1991
7. QUARLES LD, LOBAUGH B, MURPHY G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145-150, 1992
8. SALUSKY IB, RAMIREZ JA, OPPENHEIM WL, et al: Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258, 1994
9. MATHIAS RS, SALUSKY IB, HARMON WH, et al: Renal bone disease in pediatric patients and young adults treated by hemodialysis in a children's hospital. J Am Soc Nephrol 12:1938-1946, 1993
10. NUSSBAUM SR, ZAHRADNIK RJ, LAVIGNE JR, et al: Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364-1367, 1987
11. BROSSARD JH, CLOUTIER M, ROY L, et al: Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values. J Clin Endocrinol Metab 81:3923-3929, 1996
12. LEPAGE R, ROY L, BROSSARD JH, et al: A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 44:805-809, 1998
13. BROSSARD JH, LEPAGE R, CARDINAL H, et al: Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 46:697-703, 2000
14. BROSSARD JH, YAMAMOTO LN, D'AMOUR P: Parathyroid hormone metabolites in renal failure: Bioactivity and clinical implications. Semin Dial 15:196-201, 2002
15. JOHN MR, GOODMAN WG, GAO P, et al: A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290, 1999
16. SLATOPOLSKY E, FINCH J, CLAY P, et al: A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753-761, 2000
17. GAO P, SCHEIBEL S, D'AMOUR P, et al: Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614, 2001
18. MONIER-FAUGERE MC, GENG Z, MAWAD H, et al: Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460-1468, 2001
19. SALOMON R, CHARBIT M, GAGNADOUX MF, et al: High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients. Pediatr Nephrol 16:1011-1014, 2001
20. NGUYEN-YAMAMOTO L, ROUSSEAU L, BROSSARD JH, et al: Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor. Endocrinology 142:1386-1392, 2001
21. COEN G, BONUCCI E, BALLANTI P, et al: PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:348-354, 2002
22. PARFITT AM, DREZNER MK, GLORIEUX FH, et al: Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610, 1987
23. HANLEY JA, MENEIL BJ: The meaning and use of the area under a receiving operating charactersitic (ROC) curve. Radiology 143:29-36, 1982
24. SANCHEZ CP, SALUSKY IB, KUIZON BD, et al: Bone disease in children and adolescents undergoing successful renal transplantation. Kidney Int 58:1358-1364, 1998
25. GOODMAN WG, RAMIREZ JA, BELIN TR, et al: Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166, 1994
26. SALUSKY IB, GOODMAN WG: Adynamic renal osteodystrophy: Is there a problem? J Am Soc Nephrol 12:1978-1985, 2001
27. ANDRESS DL, HERCZ G, KOPP JB, et al: Bone histomorphometry of renal osteodystrophy in diabetic patients. J Bone Miner Res 2:525-531, 1987
28. PEI Y, HERCZ G, GREENWOOD C, et al: Renal osteodystrophy in diabetic patients. Kidney Int 44:159-164, 1993
29. SHIRES R, TEITELBAUM SL, BERGFELD MA, et al: The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 97:231-240, 1981
30. BALLANTI P, COEN G, MAZZAFERRO S, et al: Histomorphometric assessment of bone turnover in uraemic patients: Comparison between activation frequency and bone formation rate. Histopathology 38:571-583, 2001
31. QI Q, MONIER-FAUGERE MC, GENG Z, MALLUCHE HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 26:622-631, 1995
32. SALUSKY IB, KUIZON BD, BELIN T, et al: Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration. Kidney Int 54:907-914, 1998
33. ANDRESS DL, NORRIS KC, COBURN JW, et al: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279, 1989
34. SCHMITT CP, HUBER D, MEHLS O, et al: Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism. J Am Soc Nephrol 9:1832-1844, 1998
35. NGUYEN-YAMAMOTO L, ROUSSEAU L, BROSSARD JH, et al: Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays. Eur J Endocrinol 147:123-131, 2002
36. DIVIETI P, JOHN MR, JÜPPNER H, BRINGHURST FR: Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 143:171-176, 2002
37. MAYER GP, KEATON JA, HURST JC, HABENER JF: Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology 104:1778-1784, 1979
38. 2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs. J Bone Miner Res 11:1075-1085, 1996
39. MASSRY SG, COBURN JW, LEE DBN, et al: Skeletal resistance to parathyroid hormone in renal failure. Ann Intern Med 78:357-364, 1973
40. UREÑA P, MANNSTADT M, HRUBY M, et al: Parathyroidectomy does not prevent the renal PTH/PTHrP receptor down-regulation in uremic rats. Kidney Int 47:1797-1805, 1995
41. UREÑA P, FERREIRA A, MORIEUX C, et al: PTH/PTHrP receptor mRNA is downregulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 11:2008-2016, 1996
42. SANCHEZ CP, SALUSKY IB, KUIZON BD, et al: Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887, 1998